Clinical Trial Update: A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating HC-1119 single-dose pharmacokinetics and the effect of food on its pharmacokinetics in metastatic castration-resistant prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• HC-1119

Snippet

Sponsor: Hinova Pharmaceuticals Inc. | Conditions: Metastatic Castration Resistant Prostate Cancer | Phase 1 | Status: COMPLETED